Thunderstorm asthma in spring
This week marks the beginning of spring and National Asthma Week, a time when the National Asthma Council (NAC) urges Australians with asthma to...
What you missed at PSA22 – Day 1
PSA22 kicked off with a bang, with a day full of major announcements, therapeutic updates, and policy and practice insights.
PSA budget submission aims to improve health of nation
A proposal to support residential aged care facilities to directly engage pharmacists is among the strategic measures put forward by PSA in its 2021–22 Federal Budget Submission.
The challenges of implementing the VAD Act
As the date for implementation of the Voluntary Assisted Dying (VAD) Act moves closer, the development of clinical practices around the law is underway....
Complementary medicines: Rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by joint inflammation. The immune system attacks the tissue lining the joints (synovial membrane), causing...
The pain of uncertainty: Managing pain without codeine
With over-the-counter (OTC) codeine products being upscheduled, pharmacists and pharmacy staff need to review and understand every patient’s pain. In doing so, there’s an...
